TRANSCENTA HOLDING - A Global Fully Integrated Biotherapeutics Company
Transcenta, Biologics, Antibody, Claudin 18.2
TST973 is a best-in-class antibody with prolonged half-life. TST973 is designed for the treatment of patients with severe osteoporosis at risk of fracture with less frequent dosing. It is at preclinical stage.
